Option Care Health Q2 revenue up 15.4%, beats estimates
Overview
Option Care Health Q2 revenue rises 15.4% yr/yr, beating analyst expectations
Adjusted EBITDA for Q2 beats consensus, indicating strong operational performance
Company repurchased $50 mln of stock in Q2
Outlook
Option Care Health sees 2025 net revenue of $5.50 bln to $5.65 bln
Company expects 2025 adjusted EPS of $1.65 to $1.72
Option Care Health anticipates 2025 adjusted EBITDA of $465 mln to $475 mln
Company projects 2025 cash flow from operations of at least $320 mln
Result Drivers
REVENUE GROWTH - Driven by strong clinical outcomes and cost reduction strategies, per CEO John C. Rademacher
ADJUSTED EPS INCREASE - Improved operational efficiency contributed to a 10.8% rise in adjusted diluted EPS
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $1.42 bln | $1.35 bln (9 Analysts) |
Q2 Net Income |
| $50.50 mln |
|
Q2 Adjusted EBITDA | Beat | $114 mln | $110.70 mln (8 Analysts) |
Q2 Gross Profit |
| $269 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Option Care Health Inc is $39.00, about 22.7% above its July 29 closing price of $30.13
Press Release: ID:nGNX99Pstd
